{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:01:18Z","timestamp":1785326478176,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017511","name":"Metro North Hospital and Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.urolonc.2024.09.016","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T01:02:16Z","timestamp":1728003736000},"page":"62.e15-62.e26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cost-effectiveness analysis of microwave ablation versus robot-assisted partial nephrectomy for patients with small renal masses in Australia"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-3456","authenticated-orcid":false,"given":"Qing","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera Jayan","family":"Senanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeewa","family":"Kularatna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"McPhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Parsonage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Eastgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.09.016_bib0001","unstructured":"Cancer Australia. Kidney cancer in Australia statistics. Accessed October 1, 2022. https:\/\/www.canceraustralia.gov.au\/cancer-types\/kidney-cancer\/statistics"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0002","unstructured":"Cancer Australia. Cancer in Australia statistics."},{"issue":"2","key":"10.1016\/j.urolonc.2024.09.016_bib0003","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1148\/radiol.210034","article-title":"How we do it: managing the indeterminate renal mass with the MRI clear cell likelihood score","volume":"302","author":"Pedrosa","year":"2021","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.urolonc.2024.09.016_bib0004","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"Escudier","year":"2019","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.09.016_bib0005","first-page":"450","article-title":"Ablative treatments for small renal masses and management of recurrences: a comprehensive review","volume":"14","author":"Aveta","year":"2024","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12094-017-1765-4","article-title":"SEOM clinical guideline for treatment of kidney cancer","volume":"20","author":"Gallardo","year":"2017","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.09.016_bib0007","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/cancers16040693","article-title":"Outcomes and techniques of robotic-assisted partial nephrectomy (RAPN) for renal hilar masses: a comprehensive systematic review","volume":"16","author":"Pandolfo","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.urolonc.2024.09.016_bib0008","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.juro.2010.12.100","article-title":"Cost-effectiveness analysis of nephron sparing options for the management of small renal masses","volume":"185","author":"Chang","year":"2011","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.09.016_bib0009","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European Association of Urology Guidelines on renal cell carcinoma: the 2019 update","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.09.016_bib0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.juro.2017.04.100","article-title":"Renal mass and localized renal cancer: AUA Guideline","volume":"198","author":"Campbell","year":"2017","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.09.016_bib0011","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/JCO.2016.69.9645","article-title":"Management of small renal masses: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Finelli","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.09.016_bib0012","doi-asserted-by":"crossref","first-page":"804","DOI":"10.6004\/jnccn.2017.0100","article-title":"Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Motzer","year":"2017","journal-title":"J Nat Comprehens Canc Netw"},{"issue":"2","key":"10.1016\/j.urolonc.2024.09.016_bib0013","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.5489\/cuaj.7763","article-title":"Canadian Urological Association guideline: management of small renal masses \u2013 full-text","volume":"16","author":"Richard","year":"2022","journal-title":"Can Urol Assoc J"},{"issue":"19","key":"10.1016\/j.urolonc.2024.09.016_bib0014","first-page":"279","article-title":"Chinese guidelines on the management of renal cell carcinoma (2015 edition)","volume":"3","author":"Guo","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.urology.2023.06.001","article-title":"A comparison of microwave ablation and cryoablation for the treatment of renal cell carcinoma: a systematic literature review and meta-analysis","volume":"180","author":"McClure","year":"2023","journal-title":"Urology"},{"issue":"12","key":"10.1016\/j.urolonc.2024.09.016_bib0016","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1089\/end.2023.0342","article-title":"An updated systematic review and meta-analysis on the technical, oncologic, and safety outcomes of microwave ablation in patients with renal cell carcinoma","volume":"37","author":"Wu","year":"2023","journal-title":"J Endourol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.09.016_bib0017","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/JU.0000000000002812","article-title":"Active surveillance versus immediate intervention for small renal masses: a cost-effectiveness and clinical decision analysis","volume":"208","author":"Su","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0018","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00261-022-03692-1","article-title":"Cost-effectiveness analysis: percutaneous microwave ablation vs robotic-assisted partial nephrectomy for small renal masses","volume":"48","author":"Yeaman","year":"2023","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated Reporting Guidance for Health Economic Evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0020","doi-asserted-by":"crossref","unstructured":"Senanayake S, Xia Q, Brain D, et al. Health service resource use and costs of interventional oncology procedures: a micro-costing analysis. OSF Preprints: https:\/\/doi.org\/10.31219\/osf.io\/4gpb6 (September 10, 2023).","DOI":"10.31219\/osf.io\/4gpb6"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0021","unstructured":"TreeAge Pro 2023 R. TreeAge Software LLC. Williamstown, MA; 2023."},{"issue":"7","key":"10.1016\/j.urolonc.2024.09.016_bib0022","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40273-018-0672-z","article-title":"Discounting in economic evaluations","volume":"36","author":"Attema","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0023","unstructured":"Centre for Health Economics Research and Evaluation (CHERE). Review of the Discount Rate in the PBAC guidelines. 2022."},{"issue":"5","key":"10.1016\/j.urolonc.2024.09.016_bib0024","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jval.2024.03.001","article-title":"It is time to reconsider the 3% discount rate","volume":"27","author":"Cohen","year":"2024","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/radiol.2481071448","article-title":"Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis","volume":"248","author":"Pandharipande","year":"2008","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0026","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/radiol.2481071448","article-title":"Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis","volume":"248","author":"Pandharipande","year":"2008","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0027","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/02656736.2021.1915503","article-title":"Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney","volume":"38","author":"Meng","year":"2021","journal-title":"Int J Hyperthermia"},{"issue":"2","key":"10.1016\/j.urolonc.2024.09.016_bib0028","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clgc.2023.11.004","article-title":"Perioperative and survival outcomes of patients treated with robot-assisted partial nephrectomy and percutaneous microwave ablation for small renal masses: a single center experience","volume":"22","author":"Lucignani","year":"2024","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0029","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/02656736.2021.1970826","article-title":"Local recurrence and other oncologic outcomes after percutaneous image-guided tumor ablations on stageT1b renal cell carcinoma: a systematic review and network meta-analysis","volume":"38","author":"Cazalas","year":"2021","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"10.1016\/j.urolonc.2024.09.016_bib0030","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0272989X12454577","article-title":"Modeling good research practices\u2014overview","volume":"32","author":"Caro","year":"2012","journal-title":"Med Decision Making"},{"issue":"5","key":"10.1016\/j.urolonc.2024.09.016_bib0031","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0272989X12454941","article-title":"Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2","volume":"32","author":"Roberts","year":"2012","journal-title":"Med Decis Making"},{"issue":"5","key":"10.1016\/j.urolonc.2024.09.016_bib0032","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00270-024-03695-z","article-title":"Percutaneous microwave ablation versus robot-assisted partial nephrectomy for stage I renal cell carcinoma: a propensity-matched cohort study focusing upon long-term follow-up of oncologic outcomes","volume":"47","author":"Chlorogiannis","year":"2024","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0033","doi-asserted-by":"crossref","first-page":"11.e1","DOI":"10.1016\/j.urolonc.2017.08.021","article-title":"Surgical resection of locally recurrent renal cell carcinoma after nephrectomy: oncological outcome and predictors of survival","volume":"36","author":"Herout","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0034","unstructured":"SEER Explorer. Kidney SEER 5-Year relative survival rates, 2012-2018. Natl. Cancer Institute. Accessed April 6, 2023."},{"issue":"21","key":"10.1016\/j.urolonc.2024.09.016_bib0035","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1002\/cam4.3433","article-title":"Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: an inverse probability of treatment weighting analysis","volume":"9","author":"Shi","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0036","unstructured":"The Australian Bureau of Statistics. Life expectancy. Statistics about life tables and life expectancy at birth estimates for australia, states and territories and sub-state regions. https:\/\/www.abs.gov.au\/statistics\/people\/population\/life-expectancy\/latest-release. Accessed June 27, 2023."},{"key":"10.1016\/j.urolonc.2024.09.016_bib0037","unstructured":"National Efficient Price Determination 2021\u201322 (2021)."},{"issue":"12","key":"10.1016\/j.urolonc.2024.09.016_bib0038","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00345-018-2415-3","article-title":"Quality of life outcomes in patients with localised renal cancer: a literature review","volume":"36","author":"Rossi","year":"2018","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.09.016_bib0039","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00345-014-1318-1","article-title":"Laparoscopic versus open partial nephrectomy for clinical T1 renal masses: no impact of surgical approach on perioperative complications and long-term postoperative quality of life","volume":"33","author":"Becker","year":"2015","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2009.04.023","article-title":"Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 Health Survey","volume":"57","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"issue":"50","key":"10.1016\/j.urolonc.2024.09.016_bib0041","doi-asserted-by":"crossref","first-page":"e2255","DOI":"10.1097\/MD.0000000000002255","article-title":"Radiofrequency ablation versus partial nephrectomy in treating small renal tumors: a systematic review and meta-analysis","volume":"94","author":"Yin","year":"2015","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.urolonc.2024.09.016_bib0042","first-page":"E32","article-title":"Optimizing the management of patients with small renal masses in a Canadian context: a Markov decision-analysis model","volume":"16","author":"McAlpine","year":"2022","journal-title":"Can Urol Assoc J"},{"issue":"3","key":"10.1016\/j.urolonc.2024.09.016_bib0043","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00330-022-09211-6","article-title":"Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma","volume":"33","author":"Wu","year":"2023","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.09.016_bib0044","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11136-023-03558-z","article-title":"Australian population norms for health-related quality of life measured using the EQ-5D\u20135L, and relationships with sociodemographic characteristics","volume":"33","author":"Redwood","year":"2024","journal-title":"Quality of Life Res"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0045","unstructured":"Tufts Medical Centre. Cost-Effectiveness Analysis (CEA) Registry. Accessed October 16, 2022."},{"key":"10.1016\/j.urolonc.2024.09.016_bib0046","doi-asserted-by":"crossref","unstructured":"Edney LC, Afzali HHA, Cheng TC, Karnon JJP. Estimating the reference incremental cost-effectiveness ratio for the Australian health system. 2018;36(2):239-252.","DOI":"10.1007\/s40273-017-0585-2"},{"issue":"12","key":"10.1016\/j.urolonc.2024.09.016_bib0047","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s40273-018-0697-3","article-title":"Probabilistic sensitivity analysis in cost-effectiveness models: determining model convergence in cohort models","volume":"36","author":"Hatswell","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.urolonc.2024.09.016_bib0048","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1191\/0962280202sm306ra","article-title":"Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section","volume":"11","author":"Cooper","year":"2002","journal-title":"Statist Meth Med Res"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0049","first-page":"w14626","article-title":"Adaptation of cost-effectiveness analyses to a single country: the case of bariatric surgery for obesity and overweight","volume":"148","author":"Ademi","year":"2018","journal-title":"Swiss Med Wkly"},{"issue":"34","key":"10.1016\/j.urolonc.2024.09.016_bib0050","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/eurheartj\/ehab770","article-title":"Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis","volume":"43","author":"Marquina","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.urolonc.2024.09.016_bib0051","unstructured":"(Accessed September 12, 2023) Health spending (indicator) (2023)."},{"issue":"10","key":"10.1016\/j.urolonc.2024.09.016_bib0052","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4111\/kju.2014.55.10.636","article-title":"Risk of chronic kidney disease after nephrectomy for renal cell carcinoma","volume":"55","author":"Choi","year":"2014","journal-title":"Korean J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924006574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924006574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T07:54:39Z","timestamp":1733039679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924006574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1078143924006574"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.09.016","relation":{"has-preprint":[{"id-type":"doi","id":"10.31219\/osf.io\/ud6a4","asserted-by":"object"}]},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of microwave ablation versus robot-assisted partial nephrectomy for patients with small renal masses in Australia","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}